Effect of high or low-medium accumulated dose regimes of systemic corticosteroids for hospitalised patients with exacerbated chronic obstructive pulmonary disease: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials

P. Sivapalan (Hellerup, Denmark), J. Rutishauser (Baden, Basel, Switzerland), C. Ulrik (Hvidovre, Denmark), J. Leuppi (Basel, Liestal, Switzerland), L. Pedersen (Copenhagen, Denmark), B. Mueller (Liestal, Aarau, Switzerland), J. Eklöf (Hellerup, Denmark), T. Biering-Sørensen (Hellerup, Copenhagen, Denmark), V. Gottlieb (Hellerup, Denmark), K. Armbruster (Hellerup, Denmark), J. Janner (Hvidovre, Denmark), M. Moberg (Hvidovre, Denmark), T. Lapperre (Antwerp, Belgium), T. Nielsen (Hillerød, Denmark), A. Browatzki (Hillerød, Denmark), A. Mathiousdakis (Manchester, United Kingdom), J. Vestbo (Manchester, United Kingdom), P. Schüetz (Basel, Aarau, Switzerland), J. Jensen (Hellerup, Denmark)

Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data

Session: COPD pharmacology: from basic science to real-world data
Session type: Oral Presentation
Number: 2946

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Sivapalan (Hellerup, Denmark), J. Rutishauser (Baden, Basel, Switzerland), C. Ulrik (Hvidovre, Denmark), J. Leuppi (Basel, Liestal, Switzerland), L. Pedersen (Copenhagen, Denmark), B. Mueller (Liestal, Aarau, Switzerland), J. Eklöf (Hellerup, Denmark), T. Biering-Sørensen (Hellerup, Copenhagen, Denmark), V. Gottlieb (Hellerup, Denmark), K. Armbruster (Hellerup, Denmark), J. Janner (Hvidovre, Denmark), M. Moberg (Hvidovre, Denmark), T. Lapperre (Antwerp, Belgium), T. Nielsen (Hillerød, Denmark), A. Browatzki (Hillerød, Denmark), A. Mathiousdakis (Manchester, United Kingdom), J. Vestbo (Manchester, United Kingdom), P. Schüetz (Basel, Aarau, Switzerland), J. Jensen (Hellerup, Denmark). Effect of high or low-medium accumulated dose regimes of systemic corticosteroids for hospitalised patients with exacerbated chronic obstructive pulmonary disease: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials. 2946

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Single therapeutic and supratherapeutic doses of indacaterol have little effect on systemic safety variables in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 357s Year: 2007
Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006
Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids Source: Eur Respir J 2001; 17: 337-342 Year: 2001
Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021
A comparison of the effects of lung function between low dose theophylline and oral β2-agonist in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 215s Year: 2006
Role and distribution of infectious agents in exacerbations of moderate, severe and very severe forms of chronic obstructive lung disease: a prospective trial Source: Eur Respir J 2006; 28: Suppl. 50, 735s Year: 2006
Clinical effect of different pneumococcal vaccination schedules in patients with chronic obstructive pulmonary disease (COPD): long-term follow-up results Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017
Comparison of two physiotherapy treatments in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021
Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005
The effects of atorvastatin in mustard gas exposed patients with chronic obstructive pulmonary disease: A randomized controlled trail Source: Annual Congress 2012 - COPD beyond tobacco Year: 2012
The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020
Impact of patients’ setting on the prevalence of pulmonary embolism in acute exacerbation of COPD : a meta-analysis of observational studies. Source: International Congress 2017 – Pulmonary embolism Year: 2017
Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007
Methods for therapeutic trials in COPD: lessons from the TORCH trial Source: Eur Respir J 2009; 34: 1018-1023 Year: 2009
Patient and carer preference in two models of care for acute exacerbation of chronic obstructive pulmonary disease: results of a randomized controlled trial Source: Eur Respir J 2001; 18: Suppl. 33, 24s Year: 2001
Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006
The efficacy of formoterol in patients with chronic obstructive pulmonary disease (COPD) is not influenced by concomitant corticosteroid use Source: Eur Respir J 2001; 18: Suppl. 33, 515s Year: 2001
The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012
Placebo-controlled, double-blind trial of chronic, intermittent ‘pulse‘ therapy of moxifloxacin to prevent acute exacerbations in COPD patients with chronic bronchitis: baseline data Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006